Cargando…
Adverse drug events in cost-effectiveness analyses of interventions for diabetic conditions: a scoping review protocol
The objective of this review is to provide an overview of adverse drug events in cost-effectiveness analyses related to the pharmacological treatments of diabetes and diabetes-related complications. INTRODUCTION: The inclusion of adverse drug events in cost-effectiveness analyses is recognized in he...
Autores principales: | Pesonen, Mari, Kankaanpää, Eila, Jylhä, Virpi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750098/ https://www.ncbi.nlm.nih.gov/pubmed/35916006 http://dx.doi.org/10.11124/JBIES-21-00460 |
Ejemplares similares
-
Cost‐effectiveness of dexamethasone and triamcinolone for the treatment of diabetic macular oedema in Finland: A Markov‐model
por: Pesonen, Mari, et al.
Publicado: (2021) -
The Role of Social Media for Identifying Adverse Drug Events Data in Pharmacovigilance: Protocol for a Scoping Review
por: Golder, Su, et al.
Publicado: (2023) -
Cost-effectiveness of physical activity intervention in children – results based on the Physical Activity and Nutrition in Children (PANIC) study
por: Kuvaja-Köllner, Virpi, et al.
Publicado: (2021) -
Protocol of a scoping review of systematic reviews and meta-analyses about COVID-19 vaccines and associated adverse events from vaccination
por: Pranić, Shelly Melissa, et al.
Publicado: (2023) -
Incidence, causes, and consequences of preventable adverse drug events: protocol for an overview of reviews
por: Hutton, Brian, et al.
Publicado: (2016)